Frédéric Baron
Frédéric Baron
Verified email at - Homepage
Cited by
Cited by
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror, MB Maris, R Storb, F Baron, BM Sandmaier, DG Maloney, ...
Blood 106 (8), 2912-2919, 2005
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell …
ML Sorror, BM Sandmaier, BE Storer, MB Maris, F Baron, DG Maloney, ...
Journal of Clinical Oncology 25 (27), 4246-4254, 2007
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
F Baron, MB Maris, BM Sandmaier, BE Storer, M Sorror, R Diaconescu, ...
Journal of Clinical Oncology 23 (9), 1993-2003, 2005
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
F Baron, JE Baker, R Storb, TA Gooley, BM Sandmaier, MB Maris, ...
Blood 104 (8), 2254-2262, 2004
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched …
F Baron, C Lechanteur, E Willems, F Bruck, E Baudoux, L Seidel, ...
Biology of blood and marrow transplantation 16 (6), 838-847, 2010
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation …
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...
Bone marrow transplantation 50 (6), 781-789, 2015
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood …
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...
Bone marrow transplantation 51 (7), 906-912, 2016
Gemtuzumab ozogamicin versus best supportive care in older patients with newly diagnosed acute myeloid leukemia unsuitable for intensive chemotherapy: results of the randomized …
S Amadori, S Suciu, D Selleslag, F Aversa, G Gaidano, M Musso, ...
Journal of Clinical Oncology, 2016
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia …
F Baron, M Labopin, D Niederwieser, S Vigouroux, JJ Cornelissen, ...
Leukemia 26 (12), 2462-2468, 2012
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
F Baron, BM Sandmaier
Leukemia 20 (10), 1690-1700, 2006
Electron g factor engineering in IlI-V semiconductors for quantum communications
H Kosaka, AA Kiselev, FA Baron, KW Kim, E Yablonovitch
Electronics Letters 37 (7), 464-465, 2001
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ...
Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
P Tsirigotis, M Byrne, C Schmid, F Baron, F Ciceri, J Esteve, NC Gorin, ...
Bone marrow transplantation 51 (11), 1431-1438, 2016
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation
F Baron, R Storb, BE Storer, MB Maris, D Niederwieser, JA Shizuru, ...
Journal of clinical oncology 24 (25), 4150-4157, 2006
Mesenchymal stromal cells: a new tool against graft-versus-host disease?
F Baron, R Storb
Biology of Blood and Marrow Transplantation 18 (6), 822-840, 2012
Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review
F Baron, R Storb
Springer seminars in immunopathology 26 (1), 71-94, 2004
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute …
S Giebel, A Czyz, O Ottmann, F Baron, E Brissot, F Ciceri, JJ Cornelissen, ...
Cancer 122 (19), 2941-2951, 2016
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after …
F Baron, MB Maris, BE Storer, BM Sandmaier, JP Panse, TR Chauncey, ...
Leukemia 19 (5), 822-828, 2005
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical …
F Baron, M Labopin, D Blaise, L Lopez-Corral, S Vigouroux, C Craddock, ...
Bone marrow transplantation 49 (3), 389-396, 2014
Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo
J Cuende, S Liénart, O Dedobbeleer, B van der Woning, G De Boeck, ...
Science translational medicine 7 (284), 284ra56-284ra56, 2015
The system can't perform the operation now. Try again later.
Articles 1–20